Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Comprehensive tumor molecular profile analysis in clinical practice

Fig. 2

Tier Classification of the 936 pathogenic variants identified in the 610 tumors analyzed based on their predictive value. 1A.1: Biomarkers related to on-label treatment, 1A.2: biomarkers included in guidelines, 1B: biomarkers with strong evidence of correlation to treatment, 2C.1: biomarkers related to off-label treatment, 2C.1: biomarkers related to clinical trials, 2D: biomarkers with preclinical evidence of actionability, 3: biomarkers with unknown actionability

Back to article page